TRUE Private Wealth Advisors’s Intersect ENT, Inc XENT Stock Holding History

TRUE Private Wealth Advisors’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-45	Closed	-$1K	–	874
2019 Q4	$1K	Buy	+45	New	+$912	﹤0.01%	788
2019 Q3	–	Sell	-45	Closed	-$1K	–	781
2019 Q2	$1K	Buy	+45	New	+$1.21K	﹤0.01%	778
2018 Q4	–	Sell	-25	Closed	-$719	–	993
2018 Q3	$719	Buy	+25	New	+$751	﹤0.01%	1080

Other funds holding XENT

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

TRUE Private Wealth Advisors's XENT Position: Q1 2020 in Review

TRUE Private Wealth Advisors sold out of Intersect ENT, Inc (XENT) in Q1 2020, closing a stake of 45 shares — an estimated $1K sold.

TRUE Private Wealth Advisors first reported a position in XENT in Q3 2018 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 121 funds tracked by Wall St. Rank hold XENT as of Q1 2020.

TRUE Private Wealth Advisors reported no remaining Intersect ENT, Inc position as of Q1 2020 after selling out during the quarter.
TRUE Private Wealth Advisors sold 45 Intersect ENT, Inc shares in Q1 2020, an estimated $1K.
TRUE Private Wealth Advisors first reported a position in Intersect ENT, Inc in Q3 2018 and held it in 3 quarters.
TRUE Private Wealth Advisors's Intersect ENT, Inc position peaked at $1K in Q4 2019.
121 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q1 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q1 2020, filed 20 Apr 2020.